What the research examined
A retrospective study followed muscle-related measurements in older adults with type 2 diabetes who received semaglutide. The authors reported associations involving muscle loss and functional change during follow-up, bringing attention to outcomes beyond body weight alone.
How to interpret the findings
An observational association does not isolate the effect of a medicine from age, diabetes, nutrition, activity, or other differences. This study cannot establish a uniform effect across all GLP-1 medicines or predict an individual outcome.
Research literature
- Semaglutide Therapy and Accelerated Sarcopenia in Older Adults with Type 2 Diabetes: A 24-Month Retrospective Cohort Study.
Drug design, development and therapy · 2025 · PMID 40631351
Links open the indexed paper records. Summaries are based on those records and their available abstracts, not a systematic review or a full-text appraisal of every study.